Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-PHP vs TCbHP in Neoadjuvant HER2+ Breast Cancer
NCT07057427Phase 3Recruiting
- Sponsor
- Henan Cancer Hospital
- Start
- Jun 2025
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel in breast cancer, sponsored by Henan Cancer Hospital. Started Jun 2025; status: recruiting.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07057427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07057427.